Back to search
Cancer Harboring BRAF Alterations
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cancer Harboring BRAF Alterations trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Cancer Harboring BRAF Alterations trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Patients with metastatic or unresectable locally advanced malignancies harboring BRAF genomic alterations, the biological target of vemurafenib, and who are no…
This BVD-523-ABC study builds on the safety and clinical activity experience of previous studies that have evaluated ulixertinib as a novel targeted cancer trea…